A citation-based method for searching scientific literature

Sergio Ortiz-Espinosa, Xabier Morales, Yaiza Senent, Diego Alignani, Beatriz Tavira, Irati Macaya, Borja Ruiz, Haritz Moreno, Ana Remírez, Cristina Sainz, Alejandro Rodriguez-Pena, Alvaro Oyarbide, Mikel Ariz, Maria P Andueza, Karmele Valencia, Alvaro Teijeira, Kai Hoehlig, Axel Vater, Barbara Rolfe, Trent M Woodruff, Jose Maria Lopez-Picazo, Silvestre Vicent, Grazyna Kochan, David Escors, Ignacio Gil-Bazo, Jose Luis Perez-Gracia, Luis M Montuenga, John D Lambris, Carlos Ortiz de Solorzano, Fernando Lecanda, Daniel Ajona, Ruben Pio. Cancer Lett 2022
Times Cited: 4







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer.
Erminia Massarelli, Vincent K Lam, Edwin R Parra, Jaime Rodriguez-Canales, Carmen Behrens, Lixia Diao, Jing Wang, Jorge Blando, Lauren A Byers, Niranjan Yanamandra,[...]. J Immunother Cancer 2019
21
25


Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics.
Hugo Arasanz, Miren Zuazo, Ana Bocanegra, María Gato, Maite Martínez-Aguillo, Idoia Morilla, Gonzalo Fernández, Berta Hernández, Paúl López, Nerea Alberdi,[...]. Cancers (Basel) 2020
41
25

Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies.
Yuming Zhao, Dengyang Zhang, Yao Guo, Bo Lu, Zhizhuang Joe Zhao, Xiaojun Xu, Yun Chen. Front Oncol 2021
8
25

Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.
Ugur Sahin, Michael Koslowski, Karl Dhaene, Dirk Usener, Gunda Brandenburg, Gerhard Seitz, Christoph Huber, Ozlem Türeci. Clin Cancer Res 2008
131
25

Treatment of metastatic non-small cell lung cancer with NY-ESO-1 specific TCR engineered-T cells in a phase I clinical trial: A case report.
Yan Xia, Xiaopeng Tian, Juntao Wang, Dongjuan Qiao, Xianhao Liu, Liang Xiao, Wenli Liang, Dongcheng Ban, Junjun Chu, Jiaming Yu,[...]. Oncol Lett 2018
24
25

Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung.
Youngwook Kim, Hyo Song Kim, Zheng Yun Cui, Hye-Sook Lee, Jin Seok Ahn, Chan Keum Park, Keunchil Park, Myung-Ju Ahn. Anticancer Res 2009
31
25


CAR T Cells.
Ranjit Nair, Jason Westin. Adv Exp Med Biol 2021
1
100

PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells.
Xinru Wei, Yunxin Lai, Jin Li, Le Qin, Youdi Xu, Ruocong Zhao, Baiheng Li, Simiao Lin, Suna Wang, Qiting Wu,[...]. Oncoimmunology 2017
61
25

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.
Renier J Brentjens, Jean-Baptiste Latouche, Elmer Santos, Francesc Marti, Michael C Gong, Clay Lyddane, Philip D King, Steven Larson, Mark Weiss, Isabelle Rivière,[...]. Nat Med 2003
456
25

GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Jing Ning, Shenyi Jiang, Xiaoxi Li, Yang Wang, Xuhong Deng, Zhiqiang Zhang, Lijie He, Daqing Wang, Youhong Jiang. BMC Pulm Med 2021
3
33

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Julie R Brahmer, Scott S Tykodi, Laura Q M Chow, Wen-Jen Hwu, Suzanne L Topalian, Patrick Hwu, Charles G Drake, Luis H Camacho, John Kauh, Kunle Odunsi,[...]. N Engl J Med 2012
25

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
Julie R Brahmer, Charles G Drake, Ira Wollner, John D Powderly, Joel Picus, William H Sharfman, Elizabeth Stankevich, Alice Pons, Theresa M Salay, Tracee L McMiller,[...]. J Clin Oncol 2010
25

Adoptive T-Cell Therapy for Solid Tumors.
Oladapo Yeku, Xinghuo Li, Renier J Brentjens. Am Soc Clin Oncol Educ Book 2017
41
25

CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape.
Alba Rodriguez-Garcia, Asis Palazon, Estela Noguera-Ortega, Daniel J Powell, Sonia Guedan. Front Immunol 2020
70
25

Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients.
Yajun Zhang, Zhiwei Zhang, Yongmei Ding, Yuan Fang, Pei Wang, Wenqi Chu, Zhenlin Jin, Xintao Yang, Jiangtao Wang, Jinxing Lou,[...]. J Cancer Res Clin Oncol 2021
12
25

Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis.
S Yoshida, S Fukumoto, H Kawaguchi, S Sato, R Ueda, K Furukawa. Cancer Res 2001
126
25

DLL3: an emerging target in small cell lung cancer.
Dwight H Owen, Michael J Giffin, Julie M Bailis, Marie-Anne Damiette Smit, David P Carbone, Kai He. J Hematol Oncol 2019
67
25

CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy.
Joseph M Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell, Yunpeng Ma, David R Gandara, Robert T O'Donnell. Cancer Res 2012
18
25

Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.
Meenakshi Hegde, Amanda Corder, Kevin K H Chow, Malini Mukherjee, Aidin Ashoori, Yvonne Kew, Yi Jonathan Zhang, David S Baskin, Fatima A Merchant, Vita S Brawley,[...]. Mol Ther 2013
234
25

Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma.
Julie R Park, David L Digiusto, Marilyn Slovak, Christine Wright, Araceli Naranjo, Jamie Wagner, Hunsar B Meechoovet, Cherrilyn Bautista, Wen-Chung Chang, Julie R Ostberg,[...]. Mol Ther 2007
409
25

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, Scott N Gettinger, David C Smith, David F McDermott, John D Powderly, Richard D Carvajal, Jeffrey A Sosman, Michael B Atkins,[...]. N Engl J Med 2012
25


Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
Meenakshi Hegde, Malini Mukherjee, Zakaria Grada, Antonella Pignata, Daniel Landi, Shoba A Navai, Amanda Wakefield, Kristen Fousek, Kevin Bielamowicz, Kevin Kh Chow,[...]. J Clin Invest 2019
13
25


Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.
Sampurna Chatterjee, Lukas C Heukamp, Maike Siobal, Jakob Schöttle, Caroline Wieczorek, Martin Peifer, Davide Frasca, Mirjam Koker, Katharina König, Lydia Meder,[...]. J Clin Invest 2013
143
25

Gene modification strategies for next-generation CAR T cells against solid cancers.
Yonggui Tian, Yilu Li, Yupei Shao, Yi Zhang. J Hematol Oncol 2020
40
25

Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody.
Evan J Lipson, William H Sharfman, Charles G Drake, Ira Wollner, Janis M Taube, Robert A Anders, Haiying Xu, Sheng Yao, Alice Pons, Lieping Chen,[...]. Clin Cancer Res 2013
377
25

Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study.
Oscar Arrieta, Cynthia Villarreal-Garza, Luis Martínez-Barrera, Marcelino Morales, Yuzmiren Dorantes-Gallareta, Omar Peña-Curiel, Susana Contreras-Reyes, Eleazar Omar Macedo-Pérez, Jorge Alatorre-Alexander. BMC Cancer 2013
40
25

Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy.
Miren Zuazo, Hugo Arasanz, Gonzalo Fernández-Hinojal, Maria Jesus García-Granda, María Gato, Ana Bocanegra, Maite Martínez, Berta Hernández, Lucía Teijeira, Idoia Morilla,[...]. EMBO Mol Med 2019
82
25

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.
Suzanne L Topalian, Janis M Taube, Robert A Anders, Drew M Pardoll. Nat Rev Cancer 2016
25

B7-H3, a checkpoint molecule, as a target for cancer immunotherapy.
Shuo Yang, Wei Wei, Qi Zhao. Int J Biol Sci 2020
71
25

Cancer regression in patients after transfer of genetically engineered lymphocytes.
Richard A Morgan, Mark E Dudley, John R Wunderlich, Marybeth S Hughes, James C Yang, Richard M Sherry, Richard E Royal, Suzanne L Topalian, Udai S Kammula, Nicholas P Restifo,[...]. Science 2006
25

MUC1 downregulation inhibits non-small cell lung cancer progression in human cell lines.
Tao Xu, Daowei Li, Hongmei Wang, Taohua Zheng, Guangqiang Wang, Ying Xin. Exp Ther Med 2017
17
25

T cell exclusion, immune privilege, and the tumor microenvironment.
Johanna A Joyce, Douglas T Fearon. Science 2015
25

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Patrick Micke, Johanna Sofia Margareta Mattsson, Karolina Edlund, Miriam Lohr, Karin Jirström, Anders Berglund, Johan Botling, Jörg Rahnenfuehrer, Millaray Marincevic, Fredrik Pontén,[...]. Int J Cancer 2014
54
25


Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.
Lauren J Bayne, Gregory L Beatty, Nirag Jhala, Carolyn E Clark, Andrew D Rhim, Ben Z Stanger, Robert H Vonderheide. Cancer Cell 2012
612
25

MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours.
Mikiya Ishihara, Shinichi Kageyama, Yoshihiro Miyahara, Takeshi Ishikawa, Shugo Ueda, Norihito Soga, Hiroaki Naota, Katsumi Mukai, Naozumi Harada, Hiroaki Ikeda,[...]. BMC Cancer 2020
13
25

Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward.
Jian Li, Wenwen Li, Kejia Huang, Yang Zhang, Gary Kupfer, Qi Zhao. J Hematol Oncol 2018
120
25

EGFR mutations and lung cancer.
Gilda da Cunha Santos, Frances A Shepherd, Ming Sound Tsao. Annu Rev Pathol 2011
372
25

OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers.
Yayi He, Xiaoshen Zhang, Keyi Jia, Rafal Dziadziuszko, Sha Zhao, Juan Deng, Hao Wang, Fred R Hirsch, Caicun Zhou. Transl Lung Cancer Res 2019
24
25

B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
Yingjie Jin, Pei Zhang, Juan Li, Jianqiang Zhao, Chuanyong Liu, Fei Yang, Dong Yang, Aiqin Gao, Wenli Lin, Xiaoxia Ma,[...]. Int J Clin Exp Pathol 2015
36
25

Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors.
Hélène Salmon, Katarzyna Franciszkiewicz, Diane Damotte, Marie-Caroline Dieu-Nosjean, Pierre Validire, Alain Trautmann, Fathia Mami-Chouaib, Emmanuel Donnadieu. J Clin Invest 2012
462
25


Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.
Brian G Till, Michael C Jensen, Jinjuan Wang, Eric Y Chen, Brent L Wood, Harvey A Greisman, Xiaojun Qian, Scott E James, Andrew Raubitschek, Stephen J Forman,[...]. Blood 2008
497
25

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.
Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, Victor Olivas, Valerie Au, Thomas LaFramboise, Mohamed Abdel-Rahman, Xiaoqi Wang, Alan D Levine, Jin Kyung Rho,[...]. Nat Genet 2012
837
25

TRUCKs: the fourth generation of CARs.
Markus Chmielewski, Hinrich Abken. Expert Opin Biol Ther 2015
289
25

Chimeric Antigen Receptor T Cells: A Race to Revolutionize Cancer Therapy.
Marion Subklewe, Michael von Bergwelt-Baildon, Andreas Humpe. Transfus Med Hemother 2019
50
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.